Maki Nakao, M.D., Ph.D. Appointed as Clinic Director of TOKYO RELIFE CLINIC

TOKYO RELIFE CLINIC

General Incorporated Association Tokyo Relife (Representative Director: Yoshiaki Furuyama, Location: Ginza, Chuo-ku, Tokyo) is pleased to announce that Dr. Maki Nakao, M.D., Ph.D., board-certified anti-aging medicine specialist, has been appointed Medical Director of Tokyo Relife Clinic, effective 2026.

Significance of Appointment

Dr. Nakao graduated from St. Marianna University School of Medicine in 1997 and earned her Ph.D. in Regenerative Medicine and Immunopathology in 2009. That same year, she joined Massachusetts Eye and Ear, Harvard Medical School as a research fellow, establishing comprehensive expertise spanning basic research to clinical application.

Dr. Nakao has actively pursued stem cell research, including ES and iPS cells, continuously advancing cutting-edge knowledge in regenerative medicine.

Her practice—integrating extensive clinical experience with regenerative and anti-aging medicine expertise—embodies Tokyo Relife's core "Age Management Medicine" philosophy.

Strengthened Clinical Focus

With Dr. Nakao's appointment, Tokyo Relife Clinic will enhance:

  • Stem cell-centered cellular therapies
  • Evidence-based advanced medical care
  • Integrated regenerative and anti-aging medicine systems
  • Academic medicine bridging research and clinical practice

Through these initiatives, we provide scientifically rigorous and personalized medical care for diverse patient needs.

2. Profile

Maki Nakao, M.D., Ph.D. Medical Director, Tokyo Relife Clinic

  • 1997 – Graduated from St. Marianna University School of Medicine
  • 2005 – Completed Graduate Studies in Regenerative Medicine and Immunopathology, St. Marianna University
  • 2009 – PhD in Medicine, St. Marianna University
  • 2009 – Research Fellow, Massachusetts Eye and Ear Infirmary, Harvard Medical School
  • 2026 – Appointed Director, Tokyo Relife Clinic

Professional Affiliations

  • Japanese Ophthalmological Society
  • Japan Glaucoma Society
  • Japanese Society for Regenerative Medicine
  • The Association for Research in Vision and Ophthalmology (ARVO)
  • Japanese Society of Anti-Aging Medicine
  • Japan Society of Aesthetic Surgery

Certifications

  • Doctor of Philosophy (PhD), Medicine
  • Board-Certified Specialist, Japanese Society of Anti-Aging Medicine
  • Board-Certified Ophthalmologist, Japanese Ophthalmological Society
  • Certified Physician, Juvéderm Vista®
    Certified Physician, Botox Vista®

3. Comment from Dr. Maki Nakao, Medical Director

I am honored to serve as Medical Director of Tokyo Relife Clinic.

In our super-aging society, medicine must evolve beyond simply treating diseases. Scientifically addressing aging itself to maximize longevity is becoming increasingly important.

Through my research in regenerative medicine and immunopathology, and training at international research institutions, I have explored medicine that bridges basic science and clinical practice. I will now apply this expertise to advance care that integrates cellular-level aging control with personalized medicine.

Through careful dialogue with each patient, I am committed to providing evidence-based advanced medical care that contributes to truly meaningful well-being.

End

【Contact for Inquiries】

Clinic Name

TOKYO RELIFE CLINIC

Address

TORAYA Ginza Building 6–8F, 7-8-17 Ginza, Chuo-ku, Tokyo 104-0061, Japan

TEL

0120-660-329 (Office Hours: 10:00–19:00)

Website

https://www.tokyo-relife.com

Contact

https://tokyo-relife.com/contact

 *Please select “Other” when submitting your inquiry.

RELATED ARTICLES